LEO Pharma to acquire Bayer’s dermatology unit

LEO Pharma has entered into a definitive agreement to buy Bayer's global prescription dermatology unit. The portfolio to be acquired includes branded topical prescription...

AstraZeneca sells rights for Atacand to Cheplapharm

AstraZeneca has agreed to sell the commercial rights to Atacand (candesartan cilexetil) and Atacand Plus (fixed-dose combination of candesartan cilexetil and hydrochlorothiazide) in Europe...

NanoGenics acquired to advance gene therapy

The Scottish Biotech company Ryboquin, announces the acquisition of Nanogenic Solutions, to form a new product and platform company, Nanogenics Limited. The combined company,...

EUSA Pharma announce acquisition of SYLVANT® from Janssen

EUSA Pharma acquires SYLVANT from Janssen for $115 million

BioIVT acquires Optivia Biotechnology

BioIVT, a provider of research models and services for drug development, has announced that it has acquired Santa Clara, CA-based Optivia Biotechnology and its...

Sanofi and Advent finalise negotiations for the acquisition of Zentiva

Sanofi and Advent International (Advent) have finished negotiations for the acquisition of Zentiva - Sanofi's European generics business. Advent and the companies have signed a Share Purchase Agreement worth €1.9 billion...

Takeda ups bid to $65 billion in negotiations to buy Shire

Takeda has increased offer to buy Shire for a mix of stock and cash worth ~$65 billion

Merck to sell Consumer Health to Procter & Gamble

Merck has sold its global Consumer Health business to Procter & Gamble

Advent in negotiations to acquire Sanofi’s generics business

Advent and Sanofi are in negotiations under which Advent would acquire Zentiva,

Certara acquires Analytica Laser

Certara announced it has acquired Analytica Laser which uses health economics and outcomes research (HEOR)

Latest articles

ViiV Healthcare continues innovative partnership to transform HIV care

ViiV Healthcare continues innovative partnership to transform HIV care

ViiV Healthcare and Chelsea and Westminster Hospital NHS Foundation Trust are continuing their innovative partnership to transform HIV patient care with the launch of...
Next stage of COVID-19 vaccination programme begins

Next stage of COVID-19 vaccination programme begins

The NHS has begun the next stage of its vaccine roll-out programme to a further two priority groups today - those aged 70 and...
GSK announces NICE recommendation for ovarian cancer treatment

NICE recommendation for GSK’s ovarian cancer treatment

National Institute for Health and Care Excellence (NICE) has recommended GSK’s ZEJULA®▼ (niraparib) on the NHS in England for women with advanced high-grade epithelial...

Popular articles

Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
JCVI updates priority list for COVID-19 vaccine

JCVI updates priority list for COVID-19 vaccine

The Joint Committee on Vaccination and Immunisation (JCVI) has advised that the first priorities for any COVID-19 vaccination programme should be the prevention of...
Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Nasal spray to protect against COVID-19 is ready for use in humans

Nasal spray to protect against COVID-19 is ready for use in humans

A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...
GSK announces NICE recommendation for ovarian cancer treatment

NICE recommendation for GSK’s ovarian cancer treatment

National Institute for Health and Care Excellence (NICE) has recommended GSK’s ZEJULA®▼ (niraparib) on the NHS in England for women with advanced high-grade epithelial...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription